"B7 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of cell-surface proteins found on ANTIGEN-PRESENTING CELLS. B7 antigens are ligands for specific cell surface receptor subtypes found on T-CELLS. They play an immunomodulatory role by stimulating or inhibiting the T-CELL activation process.
| Descriptor ID |
D060887
|
| MeSH Number(s) |
D12.776.467.150 D12.776.543.095 D23.050.301.285 D23.529.168
|
| Concept/Terms |
B7 Antigens- B7 Antigens
- Antigens, B7
- Antigen, B7
- B-7 Antigen
- Antigen, B-7
- B 7 Antigen
- B7 Costimulatory Molecules
- Costimulatory Molecules, B7
- B7 Molecules
- Molecules, B7
- B7 Antigen
|
Below are MeSH descriptors whose meaning is more general than "B7 Antigens".
Below are MeSH descriptors whose meaning is more specific than "B7 Antigens".
This graph shows the total number of publications written about "B7 Antigens" by people in this website by year, and whether "B7 Antigens" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "B7 Antigens" by people in Profiles.
-
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functions. J Clin Invest. 2025 Jan 02; 135(4).
-
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer Res Commun. 2024 05 30; 4(5):1369-1379.
-
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. ESMO Open. 2024 Apr; 9(4):102942.
-
VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance. Cancer Immunol Res. 2023 01 03; 11(1):38-55.
-
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model. Mol Cancer Ther. 2022 06 01; 21(6):999-1009.
-
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer. Cancer. 2022 06 15; 128(12):2269-2280.
-
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy. Proc Natl Acad Sci U S A. 2021 01 26; 118(4).
-
Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity. Oncoimmunology. 2020; 9(1):1708065.
-
Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection. Clin Cancer Res. 2020 05 01; 26(9):2140-2150.
-
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Cancer Immunol Res. 2019 07; 7(7):1079-1090.